HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NTP testing

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic ingredients nominated for photocarcinogenicity and/or phototoxicity testing clear program's Board of Scientific Counselors during meeting in Research Triangle Park, N.C. May 25. D&C Red No. 27 and No. 28, all-trans-retinyl palmitate, lemon and lime oils, bilberry fruit extract, black cohosh and senna endorsed for testing without formal vote. Last step for nominations is NTP Executive Committee. Nominations for 10th Report on Carcinogens also await Executive Committee review. At a December meeting, NTP Board of Scientific Counselors subcommittee voted against listing non-asbestiform talc in report, saying additional research is needed on risk (1"The Rose Sheet" Jan. 1, p. 11). NIEHS review committee and Executive Committee Interagency Working Group on 10th report previously voted to list non-asbestiform talc as "reasonably anticipated to be a human carcinogen"
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS009291

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel